AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30561704
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen (1 g every eight hours, three doses)
Trial: 30561704
Drug: Oral acetaminophen
RxNorm normalized name: acetaminophen Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral acetaminophen (1 g every eight hours, three doses)
Trial: 30561704
Drug: No acetaminophen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No acetaminophen
Trial: 20139856
Drug: IFX/HC (Hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFX/HC (Hydrocortisone 250 mg intravenously)
Trial: 20139856
Drug: IFX/AZA (Azathioprine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFX/AZA (Azathioprine 2-2.5 mg/kg/day)
Trial: 11134099
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone gel 50 mg/day
Trial: 11422108
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone patches (5 mg T/day)
Trial: 9231954
Drug: Weekly phone
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly phone calls to uncover problems and encourage use
Trial: 2902681
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg zaltidine once daily for 4 weeks
Trial: 28645949
Drug: 4.5 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 g/day S. maxima intake
Trial: 11509081
Drug: Entacapone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entacapone (200 mg with each of 2-10 daily levodopa doses)
Trial: 7607776
Drug: Group-administered questionnaire
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-administered questionnaire in the workplace
Trial: 8480685
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (10 mg Zn/d, n = 65)
Trial: 30097067
Drug: Citrulline malate
RxNorm normalized name: CITRULLINE MALATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citrulline malate (CM) 8 g (1.11:1 ratio)
Trial: 26834211
Drug: Secukinumab IV
RxNorm normalized name: Secukinumab
DrugBank: Secukinumab (DB09029)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Secukinumab IV loading 10 mg/kg at baseline, Weeks 2 and 4, then SC 150 mg every 4 weeks (n = 88)
Trial: 26834211
Drug: Secukinumab SC
RxNorm normalized name: Secukinumab
DrugBank: Secukinumab (DB09029)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Secukinumab SC loading 150 mg once weekly for 5 weeks, then every 4 weeks (n = 89)
Trial: 24145221
Drug: Ziprasidone augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone augmentation of clozapine
Trial: 18318568
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid therapy
Trial: 11180026
Drug: Moxifloxacin 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 800 mg
Trial: 20406223
Drug: Levofloxacin 1000
RxNorm normalized name: Levofloxacine
DrugBank: Levofloxacin (DB01137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levofloxacin 1000 mg
Trial: 9310011
Drug: Ciprofloxacin 1500
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 1500 mg
Trial: 10898688
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (MgSO4) at doses of 1, 2, and 3 g
Trial: 3658552
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (MgSO4)
Trial: 1811970
Drug: Intermaxillary wiring
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermaxillary wiring with subsequent functional therapy and/or functional appliances
Trial: 6347747
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of quazepam
Trial: 29098286
Drug: Topical medications
RxNorm normalized name: Procto-Med Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical medications
Trial: 24727262
Drug: Interaction between
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interaction between treatment and baseline MD
Trial: 23043563
Drug: PSA-based screening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSA-based screening with a threshold of ≥ 3.0 ng/mL
Trial: 17518105
Drug: Form priming
RxNorm normalized name: epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Form priming with related primes and targets (e.g., lou3 'hug'‐‐lou2 'hall')
Trial: 11785593
Drug: Alfentanil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil (0.5 mg IV)
Trial: 1632533
Drug: Morphine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (5 mg IV)
Trial: 7921469
Drug: PC20FEV1 <
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC20FEV1 < or = 25 mg/ml (AHR25)
Trial: 30476361
Drug: Samidorphan (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Samidorphan (10 mg)
Trial: 30476361
Drug: Samidorphan (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Samidorphan (30 mg)
Trial: 28340145
Drug: Oxycodone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (40 mg)
Trial: 9513799
Drug: Pentazocine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine (30 mg)
Trial: 8539322
Drug: Naltrexone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (100 mg)
Trial: 28117843
Drug: Lithium (serum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (serum level 0.6 mmol l-1, n=20)
Trial: 28117843
Drug: Quetiapine (flexibly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quetiapine (flexibly dosed up to 800 mg per day, n=19)
Trial: 23230135
Drug: Tamoxifen treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen treatment in pre- and postmenopausal women
Trial: 18054209
Drug: Paroxetine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine plus pindolol (2.5 mg t.i.d.)
Trial: 14621239
Drug: Control solutions
RxNorm normalized name: Accu-Chek Comfort Curve Control Solutions
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solutions (tap water, Carbopol, Carbopol-urea)
Trial: 10811092
Drug: cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cyclosporin A ophthalmic emulsion 0.05%
Trial: 10811092
Drug: cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cyclosporin A ophthalmic emulsion 0.1%
Trial: 3932051
Drug: Cimetidine 300
RxNorm normalized name: cimetidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 300 mg, q.i.d.
Trial: 20008701
Drug: Patch +
RxNorm normalized name: Patch
DrugBank: Lavender oil (DB14566)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch + lozenge
Trial: 20008701
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR + lozenge
Trial: 14564941
Drug: Daily foodlet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily foodlet containing multiple micronutrients
Trial: 14564941
Drug: Daily placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily placebo foodlet containing no micronutrients
Trial: 14564941
Drug: Weekly foodlet
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly foodlet containing multiple micronutrients (twice the dose of the daily foodlet) and placebo foodlets on other days
Trial: 14564941
Drug: Daily foodlet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily foodlet containing only 10 mg of elemental iron
Trial: 4005103
Drug: Ciclazindol hydrochloride
RxNorm normalized name: Chlorpromazine Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclazindol hydrochloride (50 mg twice daily)
Trial: 31144979
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with 0.6 g protein/kg body weight
Trial: 31144979
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with 1 g protein/kg body weight
Trial: 29566934
Drug: Once-daily 7.5mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily 7.5mg tolvaptan
Trial: 26272586
Drug: Low-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat meal (500 mg ceritinib)
Trial: 26272586
Drug: High-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat meal (500 mg ceritinib)
Trial: 24819761
Drug: 10% LF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% LF ointment
Trial: 24819761
Drug: 20% LF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% LF ointment
Trial: 15765988
Drug: 6.5 mg
RxNorm normalized name: menthol 6.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.5 mg dose of bupivacaine with 20 microg of fentanyl
Trial: 15374060
Drug: Carvedilol (6.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (6.25 mg twice daily for the first week, increased to 12.5 mg during weeks 2-4, and to 25 mg from weeks 5-12)
Trial: 11127843
Drug: Intravenous dihydralazine
RxNorm normalized name: dihydralazine
DrugBank: Dihydralazine (DB12945)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dihydralazine
Trial: 30753625
Drug: Lipid-based nutrient
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid-based nutrient supplements (LNSs) during pregnancy and postpartum plus LNSs for infants from 6 to 18 months
Trial: 30753625
Drug: Non-LNS group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-LNS group (iron and folic acid during pregnancy and 200 mg Ca for 6 months postpartum; multiple micronutrients during pregnancy and postpartum)
Trial: 27016157
Drug: Definitive abutment
RxNorm normalized name: Augmented Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Definitive abutment placed at the time of implant placement
Trial: 23907700
Drug: Simeprevir (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simeprevir (75 or 150 mg QD) with Pegylated interferon and ribavirin
Trial: 18987053
Drug: morphine 1
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: morphine 1 mg ml(‐1) plus dexmedetomidine 5 microg ml(‐1) (Group D)
Trial: 18987053
Drug: morphine 1
RxNorm normalized name: morphine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: morphine 1 mg ml(‐1) alone (Group M)
Trial: 31250182
Drug: Rehabilitation program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation program (8-week, bi-weekly education and exercise program)
Trial: 22093849
Drug: Methylprednisolone 1000
RxNorm normalized name: methylprednisolone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 1000 mg/d for 3 days
Trial: 14996518
Drug: Glimepiride (initially
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride (initially 2 mg once daily, increased by 1 mg every 2 weeks until FPG <6.7 mmol/L, maintained for 24 weeks)
Trial: 14996518
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose tolerance tests (OGTTs) conducted in the control group
Trial: 7240597
Drug: Potassium metabisulfite
RxNorm normalized name: Potassium Metabisulfite
DrugBank: Potassium metabisulfite (DB15841)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium metabisulfite (K2S2O5) oral challenges
Trial: 20214065
Drug: Acupuncture combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture combined with oral administration of Propranolol
Trial: 20214065
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Propranolol only
Trial: 16239762
Drug: Amantadine 200
RxNorm normalized name: amantadine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine 200 mg twice daily
Trial: 11851956
Drug: Mass drug
RxNorm normalized name: Xenon, isotope of mass 129
DrugBank: Xenon Xe-129 (DB17386)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mass drug administration (MDA) of diethylcarbamazine (DEC) plus ivermectin (IVR) with vector control
Trial: 28398692
Drug: 7 days
RxNorm normalized name: ZINGIBER OFFICINALE (GINGER) ROOT OIL 0.006 mg in 30 mg TOPICAL LIQUID [JAYSUING 7 Days Nail Fungus Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 days intravenous antibiotics
Trial: 28398692
Drug: 10 days
RxNorm normalized name: AlleRx 10-day Dose Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 days intravenous antibiotics
Trial: 24513025
Drug: Atomoxetine (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (60 mg)
Trial: 14722176
Drug: Fentanyl 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.5 micro g kg(‐1)
Trial: 14722176
Drug: Fentanyl 1
RxNorm normalized name: fentanyl 1.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 1 micro g kg(‐1)
Trial: 14722176
Drug: Fentanyl 2
RxNorm normalized name: fentanyl 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 2 micro g kg(‐1)
Trial: 14722176
Drug: Fentanyl (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (0.5 to 1 micro g kg(‐1))
Trial: 11712623
Drug: Netamiftide (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netamiftide (18 mg/patient per day) for 10 days
Trial: 11712623
Drug: Netamiftide (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netamiftide (18 mg/patient per day) for 5 days followed by 5 days of placebo
Trial: 9042130
Drug: Pill form
RxNorm normalized name: Methio-Form Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pill form of cholestyramine (8 gm/day)
Trial: 2835964
Drug: E +
RxNorm normalized name: Perle +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E + H 25 (Enalapril + Hydrochlorothiazide 25 mg/day)
Trial: 26967547
Drug: 15-minute 1-mA
RxNorm normalized name: TAGETES MINUTA FLOWER OIL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-minute 1-mA subsensory (sham) treatment
Trial: 9052356
Drug: Intranasal cocaine
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal cocaine
Trial: 8442748
Drug: Behaviour Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behaviour Therapy
Trial: 6626112
Drug: Placebo Medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo Medication
Trial: 29968686
Drug: Laughter therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laughter therapy program (12 sessions for 6 weeks)
Trial: 21804338
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no laughter therapy)
Trial: 25493968
Drug: Protocolized sedation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocolized sedation plus daily sedation interruption
Trial: 15565494
Drug: S-L-tryptophan
RxNorm normalized name: L-TRYPTOPHAN
DrugBank: Tryptophan (DB00150)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: S-L-tryptophan
Trial: 8306050
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone (500 micrograms four times daily) for 1 month
Trial: 2656624
Drug: Cefmetazole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefmetazole (1 g doses administered intravenously 30-90 min before incision, followed by additional doses at 8 and 16 hours later)
Trial: 30406725
Drug: Regular intermittent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular intermittent epidural injection at L3-4
Trial: 30406725
Drug: Regular intermittent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular intermittent epidural injection at L4-5
Trial: 10403264
Drug: Tramadol 200
RxNorm normalized name: TRAMADOL 200MG (RYZOLT) SA TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 200 mg/day
Trial: 28881493
Drug: Tramadol 400
RxNorm normalized name: tramadol hydrochloride 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 400 mg/day
Trial: 28881493
Drug: Tramadol (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (all doses)
Trial: 24725475
Drug: PMMA-collagen injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PMMA-collagen injections
Trial: 19201295
Drug: 1,25(OH)(2)D(3) treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,25(OH)(2)D(3) treatment for 3 weeks
Trial: 17465090
Drug: New drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drugs for the treatment of type 2 diabetes
Trial: 15382007
Drug: 0.125% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125% bupivacaine with 2 micro g/ml fentanyl
Trial: 15382007
Drug: 0.125% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125% bupivacaine with 1.5 micro g/ml clonidine
Trial: 2397544
Drug: Routine treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatments such as oryzanol, vitamin B1 and B6
Trial: 626430
Drug: Epidural placement
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural placement of saline solution
Trial: 30054173
Drug: Therapist-led VR
RxNorm normalized name: Prostin VR
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Therapist-led VR exposure therapy followed by a four-week internet-administered VR to in-vivo transition program
Trial: 23095369
Drug: hMG-HP (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hMG-HP (150 IU hMG-HP daily for a maximum of 16 days)
Trial: 17374817
Drug: Drug intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug intervention trials
Trial: 17374817
Drug: Concomitant medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant medication use and comorbidities
Trial: 78529
Drug: Flutamide 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 1.5 gm daily
Trial: 78529
Drug: Flutamide 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 0.75 gm daily
Trial: 78529
Drug: Flutamide 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 1.0 mg diethylstilbestrol daily
Trial: 21596243
Drug: Sequential bilateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential bilateral cataract surgery
Trial: 29241450
Drug: Low-dose cytarabine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cytarabine
Trial: 8914461
Drug: Low-dose etoposide
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose etoposide
Trial: 23590265
Drug: Ivacaftor (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivacaftor (150 mg orally every 12 hours for 48 weeks)
Trial: 19095219
Drug: Duloxetine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine treatment
Trial: 9465239
Drug: Ultrasound (US)
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound (US) measurement of visceral/subcutaneous adipose thickness
Trial: 9465239
Drug: Computed Tomography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computed Tomography (CT) measurement of visceral/subcutaneous adipose thickness
Trial: 7870930
Drug: remoxipride 100
RxNorm normalized name: remoxipride
DrugBank: Remoxipride (DB00409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: remoxipride 100 mg
Trial: 7870930
Drug: remoxipride 100
RxNorm normalized name: remoxipride
DrugBank: Remoxipride (DB00409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: remoxipride 100 mg plus biperiden 4 mg
Trial: 7870930
Drug: biperiden 4
RxNorm normalized name: biperiden 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: biperiden 4 mg
Trial: 2876573
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg celiprolol
Trial: 2876573
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg celiprolol plus 12.5 mg chlorthalidone
Trial: 30794658
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg)
Trial: 27046312
Drug: Topiramate (50-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (50-200 mg per day for 12 weeks)
Trial: 24998293
Drug: Passive physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passive physical therapy (Control Group)
Trial: 21741107
Drug: HbA1c≥5.7% and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HbA1c≥5.7% and/or FPG≥5.6mmol/l
Trial: 12629661
Drug: Interferon treatment
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon treatment for hepatitis C virus
Trial: 6362125
Drug: Albendazole (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (single 400 mg oral dose)